C07K

Peptides & Proteins (Biologics)

EPO Patent Bulletin

← All categories
Filter: All Correction Grant Limitation Publication Search Report

162 items

(filtered)
Publication

Pcv2 E, Pcv3 C, And Pcv4 Vaccines

EP2026030635A2 · Mar 18, 2026
Publication

Sustained Transgene Expression Of Imid Responsive Peptide Suicide Protein Fusion Polypeptides And Uses Thereof

EP2026030634A2 · Mar 18, 2026
Publication

Vaccine Antigens And Use Thereof

EP2026030201A2 · Mar 18, 2026
Publication

Prostate Specific Antigen Peptides And Uses Thereof

EP2026030428A2 · Mar 18, 2026
Publication

Optimized Dna Cassettes For Gene Therapy

EP2026030354A2 · Mar 18, 2026
Publication

Site Specific Antibody Conjugation And Antibody Drug Conjugate As Specific Example Thereof

EP4711386A2 · ABTIS Co., Ltd. · Mar 18, 2026
Publication

Methods Of Treating Psoriasis Using Il 17 Antagonists

EP4670788A2 · Novartis AG · Mar 18, 2026
Publication

Anti Axl Antibodies, Antibody Fragments And Their Immunoconjugates And Uses Thereof

EP4656204A2 · BioAtla, Inc. · Mar 18, 2026
Publication

Car For Use In The Treatment Of Hvg Disease

EP4671278A2 · Medizinische Hochschule Hannover · Mar 18, 2026
Publication

Car T Cells Against Cd79 B For The Treatment Of Non Hodgkin Lymphoma

EP4667494A2 · Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz · Mar 18, 2026
Publication

Specific Modification Of Antibody With Igg Binding Peptide

EP4699621A2 · Kagoshima University · Mar 18, 2026
Publication

Anti C Met Antibody Drug Conjugates

EP4656248A2 · AbbVie Manufacturing Management Unlimited Company · Mar 18, 2026
Publication

Antibodies Binding To Citrullinated Histone 2 A And/Or 4

EP4659807A2 · Citryll B.V. · Mar 18, 2026
Publication

T Cell Phenotypes Associated With Response To Adoptive Cell Therapy

EP4667936A2 · The United States of America, as represented by the Secretary, Department of Health and Human Services · Mar 18, 2026
Publication

Recombinant Rsv Antigens

EP4670734A2 · GlaxoSmithKline Biologicals S.A. · Mar 18, 2026
Publication

Method For Purifying Antibody Having Low Isoelectric Point

EP4671270A2 · CHUGAI SEIYAKU KABUSHIKI KAISHA · Mar 18, 2026
Publication

Feline Antibody Variants

EP4711383A2 · Zoetis Services LLC · Mar 18, 2026
Publication

Anti C1 S Antibodies And Methods Of Use Thereof

EP4652926A2 · Bioverativ USA Inc. · Mar 18, 2026
Publication

Multimeric Il 15 Based Molecules

EP4613776A2 · Altor BioScience, LLC · Mar 18, 2026
Publication

Generating Mammalian T Cell Activation Inducible Synthetic Promoters (Syn+Pro) To Improve T Cell Therapy

EP4613864A2 · Seattle Children's Hospital d/b/a Seattle Children's Research Institute · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4613773A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Bispecific Antibodies Against Cd3 And Cd20

EP4678661A2 · Genmab A/S · Mar 18, 2026
Publication

Preparation Of Factor Xa Derivatives

EP4588932A2 · ALEXION PHARMACEUTICALS, INC. · Mar 18, 2026
Publication

Therapeutic Molecules

EP4556491A2 · Crescendo Biologics Limited · Mar 18, 2026
Publication

Compositions And Methods For Treating Cancer

EP4559477A2 · Adagene AG · Mar 18, 2026
Publication

Construction And Application Of Fusion Protein Vaccine Platform

EP4566671A2 · Institute of Biophysics Chinese Academy of Sciences · Mar 18, 2026
Publication

Enhanced Delivery Of Drugs And Other Compounds To The Brain And Other Tissues

EP4548924A2 · Duke University · Mar 18, 2026
Publication

Methods For Array Synthesis

EP4556467A2 · Vibrant Holdings, LLC · Mar 18, 2026
Publication

Composition For Regulating Cancer Cell Division Or Differentiation Comprising Setdb1 Or A Setdb1 Inhibitor

EP4559526A2 · Korea Advanced Institute of Science and Technology · Mar 18, 2026
Publication

Nucleic Acid Polypeptide Compositions And Methods Of Inducing Exon Skipping

EP4556489A2 · Avidity Biosciences, Inc. · Mar 18, 2026
Publication

Synthetic Helper Genes For Enhancing Viral Production

EP2025035137A2 · Synvivia, Inc. · Mar 18, 2026
Publication

Enhanced Formulation Of Polymyxin B/ Trimethoprim And Rifampin And Methods For Ophthalmic Uses

EP2025030169A2 · Arcum Vision Inc. · Mar 18, 2026
Publication

Anti Cthrc1 T Cell Engagers And Methods Of Using The Same

EP2025015320A2 · Phenomic AI · Mar 18, 2026
Publication

Compositions And Methods For Purifying Viral Vectors

EP4709740A2 · North Carolina State University · Mar 18, 2026
Publication

Ige Binding Proteins And Uses Thereof

EP2025015286A2 · Inhibrx Biosciences, Inc. · Mar 18, 2026
Publication

Therapy For Alpha 1 Antitrypsin Deficiency

EP2025014986A2 · Precigen, Inc. · Mar 18, 2026
Publication

Compact Proteins

EP4709851A2 · Vertex Pharmaceuticals Incorporated · Mar 18, 2026
Publication

A Combination Comprising Lag 3 Targeting Moiety And Interleukin 10

EP4709761A2 · Elixiron Immunotherapeutics (Hong Kong) Limited · Mar 18, 2026
Publication

Compositions And Methods For Engineering T Cells For Improved Tumor Infiltration And Uses Thereof

EP4709843A2 · THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE · Mar 18, 2026
Publication

B. Burgdorferi Peptidoglycan Antibodies And Uses Thereof

EP4709421A2 · Virginia Tech Intellectual Properties, Inc. · Mar 18, 2026
Publication

Peptoid Compositions Targeting Ras Proteins And Methods Of Treatment Of Cancer Using The Same

EP4709403A2 · University of Houston System · Mar 18, 2026
Publication

Fluorescein Labeled Nerve Targeting Peptide Formulations And Related Methods

EP4709405A2 · Alume Biosciences, Inc. · Mar 18, 2026
Publication

Immunohistochemistry (Ihc) Protocols And Methods For Diagnosing And Treating Cancer Claudin 18.2

EP4710112A2 · Agilent Technologies, Inc. · Mar 18, 2026
Publication

High Concentration Formulations For Monoclonal Antibodies

EP4709760A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Human Monoclonal Antibodies For Treating Subjects Suffering From Pulmonary Fibrosis

EP4709764A2 · The Johns Hopkins University · Mar 18, 2026
Publication

Exhaled Breath Condensate Contains Extracellular Vesicles (Evs) With Mirna Cargos Of Lung Tissue Origin That Can Be Selectively Purified And Analyzed

EP4709399A2 · Hackensack Meridian Health, Inc. · Mar 18, 2026
Publication

Alkaline Phosphatase Antibodies And Uses Thereof

EP4709762A2 · Chosen Diagnostics Inc. · Mar 18, 2026
Publication

Bispecific Chimeric Antigen Receptors Targeting Bcma And Cd19

EP4695301A2 · AbelZeta Inc. · Mar 18, 2026
Publication

Vaccine Adjuvants

EP4709394A2 · Seqirus Inc. · Mar 18, 2026
Publication

Combined Targeted And Untargeted Proteomics

EP2024196780A2 · Mar 18, 2026
Publication

Developing An Anti Human Cd45 Imaging Probe For Noninvasive Detection Of Human Immune Cells

EP2024196776A2 · Mar 18, 2026
Publication

Membrane Vesicles Comprising Multiple Influenza Antigens For Vaccines

EP2024196719A2 · Mar 18, 2026
Publication

Chimeric Antibody Molecules Based On Tetrameric Teleost Immunoglobulin M

EP2024196707A2 · Mar 18, 2026
Publication

Pd 1 Agonist Antibodies And Methods Of Treating Inflammatory Or Autoimmune Skin Diseases With A Pd 1 Agonist Antibody

EP2024196694A2 · Mar 18, 2026
Publication

Targeting Prac1 In Steroid Hormone Driven Cancer

EP2024197199A2 · Mar 18, 2026
Publication

Broadly Neutralizing Human Monoclonal Antibodies That Target The Sars Cov 2 Receptor Binding Domain (Rbd)

EP2024196463A2 · Mar 18, 2026
Publication

Anti Phosphocholine Antibodies And Methods Of Use Thereof

EP2024194685A2 · Mar 18, 2026
Publication

Compositions And Methods For Recombinant Aav Production

EP4709866A2 · REGENXBIO Inc. · Mar 18, 2026
Publication

Identification Of Neoantigen Reactive T Cell Receptors

EP2024197072A2 · Mar 18, 2026
Publication

Gene Therapy

EP2024194223A2 · Mar 18, 2026
Publication

Compounds For Inducing Tissue Regeneration And Uses Thereof

EP4567043A2 · Histide AG · Mar 18, 2026
Publication

Compounds For Inducing Tissue Regeneration And Uses Thereof

EP4541810A2 · Histide AG · Mar 18, 2026
Publication

Virus Filtration Methods

EP4559926A2 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Human Immunodeficiency Virus (Hiv) Neutralizing Antibodies

EP4549461A2 · Theraclone Sciences, Inc. · Mar 18, 2026
Publication

Non Human Animals Comprising A Humanized Asgr1 Locus

EP4484562A2 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Methods Of Enhancing Immunogenicity Of Poorly Immunogenic Antigen Specific Vaccines Using Oral Yeast Beta Glucans

EP4509185A2 · Memorial Sloan Kettering Cancer Center · Mar 18, 2026
Publication

Mice Expressing A Limited Immunoglobulin Light Chain Repertoire

EP4545567A2 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compositions And Methods That Promote Hypoxia Or The Hypoxia Response For Treatment And Prevention Of Mitochondrial Dysfunction And Oxidative Stress Disorders

EP4512819A2 · The General Hospital Corporation · Mar 18, 2026
Publication

Improved Serum Albumin Binders

EP4471058A2 · Ablynx NV · Mar 18, 2026
Publication

Improved Serum Albumin Binders

EP4442709A2 · Ablynx NV · Mar 18, 2026
Publication

Improved Serum Albumin Binders

EP4442708A2 · Ablynx NV · Mar 18, 2026
Publication

Determining Antigen Recognition Through Barcoding Of Mhc Multimers

EP4484450A2 · Herlev Hospital · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising Ccn5 As Active Ingredient For Preventing Or Treating Retinal Disease

EP4365299A2 · Olives Biotherapeutics Inc. · Mar 18, 2026
Publication

Dosing Regimen For Anti Bcma Agents

EP4424709A2 · Amgen Research (Munich) GmbH · Mar 18, 2026
Publication

Human Neuregulin 1 (Nrg 1) Recombinant Fusion Protein Compositions And Methods Of Use Thereof

EP4361177A2 · Salubris Biotherapeutics, Inc. · Mar 18, 2026
Publication

Nangibotide For Use In Treating Sepsis Shock

EP4474013A2 · Inotrem · Mar 18, 2026
Publication

Variants Of Cpf1 (Cas12 A) With Altered Pam Specificity

EP4481049A2 · The General Hospital Corporation · Mar 18, 2026
Publication

Method For Producing Cd3 Positive Cell

EP4455166A2 · Kyoto University · Mar 18, 2026
Publication

Markers Of Acute Myeloid Leukemia Stem Cells

EP4470556A2 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

Enhancing The Therapeutic Activity Of An Immune Checkpoint Inhibitor

EP4342544A2 · MaineHealth · Mar 18, 2026
Publication

Methods And Compositions For Increasing Arylsulfatase A Activity In The Cns

EP4338797A2 · Armagen, Inc. · Mar 18, 2026
Publication

Methods For Treatment Using Adoptive Cell Therapy

EP4427810A2 · Juno Therapeutics, Inc. · Mar 18, 2026
Publication

Rac2 G12 V Mutant For Use In Ablating Hematopoiesis And In The Treatment Of Hematopoietic Malignancies

EP4414002A2 · Institut National de la Santé et de la Recherche Médicale · Mar 18, 2026
Publication

Long Acting Gip Peptide Analogues

EP4361173A2 · University of Copenhagen · Mar 18, 2026
Publication

Integrin Beta 6 (Itgb6) Targeting Trispecific Protein For Treatment Of Cancer

EP4633740A2 · Harpoon Therapeutics, Inc. · Mar 18, 2026
Publication

Cyclic Peptides As Pet Imaging Agents Of Granzyme B

EP4634205A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Antibodies Or Fragments Thereof For Sars Cov 2 And Variants Thereof

EP4630447A2 · Abwiz Bio, Inc. · Mar 18, 2026
Publication

Methods Of Treating Sarcoidosis With A Tnf A Antibody And Associated Compositions And Methods

EP4630056A2 · Xentria, Inc. · Mar 18, 2026
Publication

Methods For Treating Dll3 Expressing Cancer

EP4630458A2 · Amgen Inc. · Mar 18, 2026
Publication

Intelligent Design And Engineering Of Proteins

EP4630966A2 · The Regents of the University of California · Mar 18, 2026
Publication

Methods And Compositions For Improving Visual Function In Ocular Diseases And Disorders

EP4630031A2 · ONL Therapeutics, Inc. · Mar 18, 2026
Publication

Porphyria Disease Models

EP4604721A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Anti Rhd Antibodies For Treating Inflammatory Dermal Condition

EP2024050455A2 · Heitmeyer, Jamie Nicole · Mar 18, 2026
Publication

Pbase Protein, Fusion Protein, Nucleic Acid, Gene Integration System And Use

EP4636082A2 · GeCell Therapeutics, LLC. · Mar 18, 2026
Publication

Cd47 Blocking Agent And Anti Cd20 / Anti Cd3 Bispecific Antibody Combination Therapy

EP4630034A2 · Pfizer Inc. · Mar 18, 2026
Publication

Methods, Device, Kit And Compositions For Detecting Feline Lungworm

EP4499119A2 · IDEXX Laboratories, Inc. · Mar 18, 2026
Publication

Monoclonal Antibodies For Targeting The Cardiac Conduction System

EP4496817A2 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

Methods And Systems For Allele Typing

EP4504973A2 · Guardant Health, Inc. · Mar 18, 2026
Publication

Multiplex Gene Edited Cells For Cd70 Directed Cancer Immunotherapy

EP4482872A2 · Nkarta, Inc. · Mar 18, 2026
Publication

Regulatory T Cells With Chimeric Antigen Receptor Targeting Co Stimulatory Molecules To Prevent And/Or Treat Inflammatory Conditions

EP4486764A2 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Lysine Free Ubiquibody Variants For Long Lived Intracellular Protein Silencing

EP4490200A2 · Cornell University · Mar 18, 2026
Publication

Compositions And Methods For Cancer Immunotherapy

EP4475865A2 · Mural Oncology, Inc. · Mar 18, 2026
Publication

Mrna Expression And Delivery Systems

EP4476252A2 · Iowa State University Research Foundation, Inc. · Mar 18, 2026
Publication

Multispecific Binding Agents And Uses Thereof

EP4475886A2 · Exelixis, Inc. · Mar 18, 2026
Publication

Production Of Rna Polynucleotides Encoding Picornavirus

EP4514822A2 · ElevateBio Technologies, Inc. · Mar 18, 2026
Publication

Tdt Specific Chimeric Receptors And Methods Of Their Use

EP4514833A2 · Baylor College of Medicine · Mar 18, 2026
Publication

Purification Process

EP4561722A2 · GlaxoSmithKline Biologicals S.A. · Mar 18, 2026
Publication

Anti Alarmin Binding Molecules And Treatment Of Pneumonitis

EP4482522A2 · Lanier Biotherapeutics, Inc. · Mar 18, 2026
Publication

Modified Amino Acids And Uses Thereof

EP4543901A2 · University of Strathclyde · Mar 18, 2026
Publication

Vaccine Against Leptospirosis

EP4469470A2 · Yale University · Mar 18, 2026
Publication

Compositions, Devices And Methods For Treating Cns Disorders

EP4469490A2 · Sigilon Therapeutics, Inc. · Mar 18, 2026
Publication

Use Of Myostatin Inhibitor For Treating Spinal Muscular Atrophy

EP4518970A2 · Scholar Rock, Inc. · Mar 18, 2026
Publication

Vectorized Anti Complement Antibodies And Complement Agents And Administration Thereof

EP4518972A2 · RegenxBio Inc. · Mar 18, 2026
Publication

Microchip Capillary Electrophoresis Assays And Reagents

EP4317959A2 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Gas Permeable Sealing Member For Drug Container And Methods Of Assembly

EP4292576A2 · Amgen Inc. · Mar 18, 2026
Publication

Use Of The Cd2 Signaling Domain In Second Generation Chimeric Antigen Receptors

EP4275699A2 · The Trustees of the University of Pennsylvania · Mar 18, 2026
Publication

Sulfur (Vi) Fluoride Compounds And Their Use In Click Reaction

EP4295841A2 · The Scripps Research Institute · Mar 18, 2026
Publication

Formulations Of Guanylate Cyclase C Agonists And Methods Of Use

EP4309673A2 · Bausch Health Ireland Limited · Mar 18, 2026
Publication

Peptide Having Effects Of Increasing Telomerase Activity And Extending Telomere, And Composition Containing Same

EP4272829A2 · Gemvax & Kael Co., Ltd. · Mar 18, 2026
Publication

Inducible Coexpression System

EP4273257A2 · ABSCI Corporation · Mar 18, 2026
Publication

Identification Of Common Tumor Specific T Cell Receptors And Antigens

EP4249592A2 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Methods Of Altering Gene Expression By Perturbing Transcription Factor Multimers That Structure Regulatory Loops

EP4249501A2 · Whitehead Institute for Biomedical Research · Mar 18, 2026
Publication

Activin Actrii Antagonists And Uses For Treating Myelodysplastic Syndrome

EP4233889A2 · Celgene Corporation · Mar 18, 2026
Publication

Pseudotyped Viral Particles, Compositions Comprising The Same, And Uses Thereof

EP4448550A2 · Interius Biotherapeutics, Inc. · Mar 18, 2026
Publication

Cd28 Binding Antibodies And Antigen Binding Fragments Thereof

EP4448581A2 · Biolegend, Inc. · Mar 18, 2026
Publication

Therapeutic Single Domain Antibody

EP4392459A2 · Singh Biotechnology, LLC · Mar 18, 2026
Publication

Sapovirus Vaccines

EP4362975A2 · VST LLC dba Medgene Labs · Mar 18, 2026
Publication

Retargeted Retroviral Vectors Resistant To Vaccine Induced Neutralization And Compositions Or Methods Of Use Thereof

EP4433579A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Relaxin 2 Fusion Protein Analogs And Methods Of Using Same

EP4429694A2 · Tectonic Operating Company, Inc. · Mar 18, 2026
Publication

Recombinant Newcastle Disease Virus Expressing Spike Protein Of Sars Cov 2 Delta Variant And Uses Thereof

EP4408463A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Use Of Anti Il 1 Beta Antibodies

EP4218815A2 · Novartis AG · Mar 18, 2026
Publication

Antibodies For The Treatment And Prevention Of Covid 19 And Emerging Variants

EP4330279A2 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Engineering B Cell Based Protein Factories To Treat Serious Diseases

EP4326290A2 · Walking Fish Therapeutics, Inc. · Mar 18, 2026
Publication

Anti Inflammatory Siglec Proteins And Methods Of Making And Using Same

EP4323378A2 · Palleon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Engineered Antimicrobial Peptides And Usage Thereof

EP4337321A2 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Indications For Anti Prame Binders

EP4412642A2 · immatics biotechnologies GmbH · Mar 18, 2026
Publication

Biomarkers For Cancer Treatment

EP4291902A2 · Foundation Medicine, Inc. · Mar 18, 2026
Publication

Epigenetic Gene Regulation To Treat Neurological Diseases And Pain

EP4284927A2 · Navega Therapeutics, Inc. · Mar 18, 2026
Publication

Platelet Alpha Granules For Delivery Of Multiple Proteins

EP4284917A2 · Longitude Therapeutics S.r.l. · Mar 18, 2026
Publication

Cyclic Peptide Immunomodulators

EP4323380A2 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Aav8 Capsid Variants With Enhanced Liver Targeting

EP4330270A2 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Tnf Alpha And Ngf Antibodies For Veterinary Use

EP4263603A2 · Elanco US Inc. · Mar 18, 2026
Publication

Recombinant Sars Cov 2 Spike Protein Subunits, Expression And Uses Thereof

EP4208198A2 · Hawaii Biotech, Inc. · Mar 18, 2026
Publication

Methods And Treatment Involving Excess Free Light

EP4126945A2 · Avalo Therapeutics, Inc. · Mar 18, 2026
Publication

Treatment Of Inflammatory Diseases With Peptides And Pharmaceutical Compositions

EP4114430A2 · YUYU Pharma, Inc. · Mar 18, 2026
Publication

Lymphocytes Expressing Heterologous Targeting Constructs

EP4015525A2 · GammaDelta Therapeutics Limited · Mar 18, 2026
Publication

Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties

EP3888690A2 · MedImmune, LLC · Mar 18, 2026
Publication

Chimeric Proteins For Selective Lysis Of Bacteria

EP4051243A2 · Bactoclear Holdings Pte. Ltd. · Mar 18, 2026
Publication

A Cell Based Method For Determining An Activity Of Botulinum Toxin

EP3825689A2 · Hugel Inc. · Mar 18, 2026
Publication

Psma Binding Antibody And Uses Thereof

EP3693396A2 · Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg · Mar 18, 2026
Publication

Mycobacterial Antigen Compositions And Methods Of Use

EP3784275A2 · Children's National Medical Center · Mar 18, 2026
Publication

Fusion Protein Constructs For Complement Associated Disease

EP3893916A2 · Akebia Therapeutics, Inc. · Mar 18, 2026
Publication

Method For Increasing Secretion Of Recombinant Protein

EP3680343A2 · Korea Advanced Institute of Science and Technology · Mar 18, 2026
Publication

Igf 1 R Monoclonal Antibodies And Uses Thereof

EP3638320A2 · Centre for Probe Development and Commercialization · Mar 18, 2026
Publication

Binding Molecule Specific For Lrig 1 Protein And Use Thereof

EP3613772A2 · Good T Cells, Inc. · Mar 18, 2026
Publication

Compositions For The Treatment Of Disease

EP3448987A2 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Anti Human Vista Antibodies And Use Thereof

EP3442579A2 · Immunext, Inc. · Mar 18, 2026
Publication

Methods Of Treatment Using Chlorotoxin Conjugates

EP3442996A2 · Blaze Bioscience, Inc. · Mar 18, 2026
Publication

Plectin 1 Binding Antibodies And Uses Thereof

EP3439692A2 · ZIELBIO, INC. · Mar 18, 2026
Publication

Three Dimensional Printed Organs, Devices, And Matrices

EP3635105A2 · Prellis Biologics, Inc. · Mar 18, 2026
Publication

Ebola Virus Antibodies And Binding Agents Derived Therefrom

EP3487521A2 · Emory University · Mar 18, 2026
Publication

Bispecific Antibodies Against Her2 And Cd3

EP2699262A2 · Genmab A/S · Mar 18, 2026